NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness

PLoS Negl Trop Dis. 2010 May 25;4(5):e720. doi: 10.1371/journal.pntd.0000720.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Africa South of the Sahara / epidemiology
  • Antiprotozoal Agents / adverse effects
  • Antiprotozoal Agents / therapeutic use*
  • Drug Therapy, Combination
  • Eflornithine / adverse effects
  • Eflornithine / therapeutic use*
  • Endemic Diseases*
  • Humans
  • Nifurtimox / adverse effects
  • Nifurtimox / therapeutic use*
  • Trypanosoma brucei gambiense / drug effects*
  • Trypanosomiasis, African / drug therapy*
  • Trypanosomiasis, African / epidemiology*

Substances

  • Antiprotozoal Agents
  • Nifurtimox
  • Eflornithine